Cysteine protease production by human osteosarcoma cells (MG63, SAOS2) and its modulation by soluble factors

被引:10
作者
Damiens, C [1 ]
Grimaud, E [1 ]
Rousselle, AV [1 ]
Charrier, C [1 ]
Fortun, Y [1 ]
Heymann, D [1 ]
Padrines, M [1 ]
机构
[1] Fac Chirurg Dent, Lab Physiopathol Resorpt Osseuse & Mecanismes Cic, F-44042 Nantes 01, France
关键词
D O I
10.1006/cyto.1999.0593
中图分类号
Q5 [生物化学]; Q7 [分子生物学];
学科分类号
071010 ; 081704 ;
摘要
The production of cysteine protease by two human osteosarcoma cell lines (MG-63 and SaOS2) was analyzed, as well as their modulation by interleukin 1 beta (hIL-1 beta), interleukin 6 (hIL-6), insulin growth factor-1 (hIGF-1), oncostatin M (hOSM), leukemia inhibitory factor (hLIF) and growth hormone (hGH), Cysteine protease activities were detected using a synthetic substrate. The protease activities (especially cathepsin L activity) of both cell lines were increased significantly in the presence of hIL-1 beta, hIL-6 and hOSM, In contrast, hIGF-1 and hGH decreased these activities, and no effect was detectable in the presence of hLIF. The addition of antibodies against the gp-130 chain of the hIL-6 and hOSM receptors totally inhibited the stimulating effect of these two cytokines on cysteine protease activities. In increasing collagen type I degradation, hIL-1 beta, hIL-6 and hOSM could be involved in bone resorption, whereas the inhibitory action of hIGF-1 and hGH on collagen type I degradation suggest that this factor could play a role in bone formation. (C) 2000 Academic Press.
引用
收藏
页码:539 / 542
页数:4
相关论文
共 15 条
[1]   Cathepsin B activity in normal human osteoblast-like cells and human osteoblastic osteosarcoma cells (MG-63): Regulation by interleukin-1 beta and parathyroid hormone [J].
Aisa, MC ;
Rahman, S ;
Senin, U ;
Maggio, D ;
Russell, RGG .
BIOCHIMICA ET BIOPHYSICA ACTA-GENERAL SUBJECTS, 1996, 1290 (01) :29-36
[2]   GROWTH-HORMONE (GH) RECEPTORS IN CLONAL OSTEOBLAST-LIKE CELLS MEDIATE A MITOGENIC RESPONSE TO GH [J].
BARNARD, R ;
NG, KW ;
MARTIN, TJ ;
WATERS, MJ .
ENDOCRINOLOGY, 1991, 128 (03) :1459-1464
[3]   IL-6: Insights into novel biological activities [J].
Barton, BE .
CLINICAL IMMUNOLOGY AND IMMUNOPATHOLOGY, 1997, 85 (01) :16-20
[4]   Activation of the Janus kinase/STAT (signal transducer and activator of transcription) signal transduction pathway by interleukin-6-type cytokines promotes osteoblast differentiation [J].
Bellido, T ;
Borba, VZC ;
Roberson, P ;
Manolagas, SC .
ENDOCRINOLOGY, 1997, 138 (09) :3666-3676
[5]   DEGRADATION OF EXTRACELLULAR-MATRIX PROTEINS BY HUMAN CATHEPSIN-B FROM NORMAL AND TUMOR-TISSUES [J].
BUCK, MR ;
KARUSTIS, DG ;
DAY, NA ;
HONN, KV ;
SLOANE, BF .
BIOCHEMICAL JOURNAL, 1992, 282 :273-278
[6]   THE EFFECT OF LEUKEMIA INHIBITORY FACTOR ON BONE INVIVO [J].
CORNISH, J ;
CALLON, K ;
KING, A ;
EDGAR, S ;
REID, IR .
ENDOCRINOLOGY, 1993, 132 (03) :1359-1366
[7]   CELLULAR AND CLINICAL PERSPECTIVES ON SKELETAL INSULIN-LIKE GROWTH-FACTOR-I [J].
DELANY, AM ;
PASH, JM ;
CANALIS, E .
JOURNAL OF CELLULAR BIOCHEMISTRY, 1994, 55 (03) :328-333
[8]   Stimulation by parathyroid hormone of interleukin-6 and leukemia inhibitory factor expression in osteoblasts is an immediate-early gene response induced by cAMP signal transduction [J].
Greenfield, EM ;
Horowitz, MC ;
Lavish, SA .
JOURNAL OF BIOLOGICAL CHEMISTRY, 1996, 271 (18) :10984-10989
[9]   Leukaemia inhibitory factor (LIF) and oncostatin M (OSM) high affinity binding require additional receptor subunits besides GP130 and GP190 [J].
Heymann, D ;
Godard, A ;
Raher, S ;
Bentouimou, N ;
Blanchard, F ;
Cherel, M ;
Hallet, MM ;
Jacques, Y .
CYTOKINE, 1996, 8 (03) :197-205
[10]   Oncostatin-M: A new bone active cytokine that activates osteoblasts and inhibits bone resorption [J].
Jay, PR ;
Centrella, M ;
Lorenzo, J ;
Bruce, AG ;
Horowitz, MC .
ENDOCRINOLOGY, 1996, 137 (04) :1151-1158